माल्टा - अंग्रेज़ी - Malta Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - levetiracetam - film-coated tablet - levetiracetam 500 mg - antiepileptics

माल्टा - अंग्रेज़ी - Malta Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - levetiracetam - film-coated tablet - levetiracetam 750 mg - antiepileptics

माल्टा - अंग्रेज़ी - Malta Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - levetiracetam - film-coated tablet - levetiracetam 1000 mg - antiepileptics

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - levetiracetam - concentrate for solution for infusion - 100 milligram(s)/millilitre - other antiepileptics; levetiracetam

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pregabalin - oral solution - 20 milligram(s)/millilitre - other antiepileptics; pregabalin

माल्टा - अंग्रेज़ी - Malta Medicines Authority

wockhardt uk limited - levetiracetam - concentrate for solution for infusion - levetiracetam 100 milligram(s)/millilitre - antiepileptics

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - levetiracetam - oral solution - 100 milligram(s)/millilitre - other antiepileptics; levetiracetam

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

wockhardt usa llc. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonisamide capsules are contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonisamide capsules has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

maple healthcare limited - tobramycin 300mg - solution for inhalation - 300 mg/5ml - active: tobramycin 300mg excipient: sodium chloride sodium hydroxide sulfuric acid water for injection - tobramycin wockhardt is indicated for the management of cystic fibrosis patients with p. aeruginosa infections. safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev1 <25% or >75% predicted, or patients colonised with burkholderia cepacia.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

wockhardt usa llc. - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate 5 mg - zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see clinical studies (14)]. the clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to zolpidem. observed reactions include anaphylaxis and angioedema [see warnings and precautions (5.3) ]. teratogenic effects pregnancy category c there are no adequate and well-controlled studies of zolpidem tartrate tablets in pregnant women. studies in children to assess the effects of prenatal exposure to zolpidem have not been conducted; however, cases of severe neonatal respiratory depression have been reported when zolpidem was used at the end of pregnancy, especially when take